Staining for TOM20, a mitochondrial outer membrane marker, revealed a higher proportion of RA‐FLSs with fragmented mitochondria following PA treatment compared with the control group (Figure 7C). The gene discussed is TOMM20; the disease is rheumatoid arthritis.